TY - JOUR
T1 - Higher expression of activation-induced cytidine deaminase is significantly associated with Merkel cell Polyomavirus-negative Merkel cell carcinomas
AU - Matsushita, Michiko
AU - Iwasaki, Takeshi
AU - Nonaka, Daisuke
AU - Kuwamoto, Satoshi
AU - Nagata, Keiko
AU - Kato, Masako
AU - Kitamura, Yukisato
AU - Hayashi, Kazuhiko
N1 - Funding Information:
Acknowledgments: This work was supported by JSPS KAKENHI Grant Numbers JP 26460433 and 26860238.
Publisher Copyright:
© 2017, Tottori University Faculty of Medicine. All rights reserved.
PY - 2017/9/15
Y1 - 2017/9/15
N2 - Background Merkel cell carcinomas (MCCs), clinically aggressive neuroendocrine skin cancers, are divided into Merkel cell polyomavirus (MCPyV)-positive and -negative tumors, which show different clinicopathological features and may develop through different mechanisms of carcinogenesis. Aberrant expression of activation-induced cytidine deaminase (AID) as a genomic modulator was demonstrated through pathogen-related NF-κB signal in Helicobacter pylori-associated gastric cancer, adult T cell leukemia/lymphoma (HTLV-1), hepatoma (HCV), and Burkitt lymphoma (EBV). Methods To elucidate the relation of aberrant AID expression in MCPyV-positive and -negative MCCs, we evaluated immunohistochemical expressions of AID and AID-regulating factors between 24 MCPyV-positive and 17 MCPyV-negative MCCs. Results AID expression was significantly higher in MCPyV-negative MCCs than MCPyV-positive ones (P = 0.026), although expression of NF-κB p65 (phosphor S536) (AID-enhancer) was significantly higher in MCPyV-positive MCCs than MCPyV-negative ones (P = 0.034). Expressions of PAX5 and c-Myb were not significantly different between these subgroups. Expressions of AID and AID-regulating factors were not correlated to prognosis of MCC patients. Conclusion Our findings suggest that although pathogen-induced AID expression through upregulation of NF-κB may be relevant to carcinogenesis of MCPyV-positive MCCs, the significantly higher aberrant AID expression in MCPyV-negative MCCs is consistent with the fact that MCPyV-negative MCCs have an extremelyhigher mutation burden than MCPyV-positive ones.
AB - Background Merkel cell carcinomas (MCCs), clinically aggressive neuroendocrine skin cancers, are divided into Merkel cell polyomavirus (MCPyV)-positive and -negative tumors, which show different clinicopathological features and may develop through different mechanisms of carcinogenesis. Aberrant expression of activation-induced cytidine deaminase (AID) as a genomic modulator was demonstrated through pathogen-related NF-κB signal in Helicobacter pylori-associated gastric cancer, adult T cell leukemia/lymphoma (HTLV-1), hepatoma (HCV), and Burkitt lymphoma (EBV). Methods To elucidate the relation of aberrant AID expression in MCPyV-positive and -negative MCCs, we evaluated immunohistochemical expressions of AID and AID-regulating factors between 24 MCPyV-positive and 17 MCPyV-negative MCCs. Results AID expression was significantly higher in MCPyV-negative MCCs than MCPyV-positive ones (P = 0.026), although expression of NF-κB p65 (phosphor S536) (AID-enhancer) was significantly higher in MCPyV-positive MCCs than MCPyV-negative ones (P = 0.034). Expressions of PAX5 and c-Myb were not significantly different between these subgroups. Expressions of AID and AID-regulating factors were not correlated to prognosis of MCC patients. Conclusion Our findings suggest that although pathogen-induced AID expression through upregulation of NF-κB may be relevant to carcinogenesis of MCPyV-positive MCCs, the significantly higher aberrant AID expression in MCPyV-negative MCCs is consistent with the fact that MCPyV-negative MCCs have an extremelyhigher mutation burden than MCPyV-positive ones.
UR - http://www.scopus.com/inward/record.url?scp=85029671384&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029671384&partnerID=8YFLogxK
U2 - 10.33160/yam.2017.09.002
DO - 10.33160/yam.2017.09.002
M3 - Article
AN - SCOPUS:85029671384
SN - 0513-5710
VL - 60
SP - 145
EP - 153
JO - Yonago Acta Medica
JF - Yonago Acta Medica
IS - 3
ER -